Concepedia

Trastuzumab in combination with cisplatin and gemcitabine in patients with Her2-overexpressing, untreated, advanced non-small cell lung cancer: report of a phase II trial and findings regarding optimal identification of patients with Her2-overexpressing disease

Ralph Zinner, Bonnie S. Glisson, Frank V. Fossella, Katherine M.W. Pisters, Merril Kies, Pamela M. Lee, Erminia Massarelli, Bradley S. Sabloff, Herbert A. Fritsche, Jae Y. Ro,

Lung Cancer · 2003 · 125 citations · 39 references

DOI

Concepts

References

39

Practical Statistics for Medical Research.

Sophie Walter, Daniel Altman · Biometrics · 1992 · 11.7K citations

, , +12

Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

Dennis J. Slamon, Brian Leyland‐Jones, Steven Shak et al. · New England Journal of Medicine · 2001 · 11.5K citations · Full text

, , +10

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples

Richard Peto, M. C. Pike, P. Armitage et al. · British Journal of Cancer · 1977 · 8.4K citations · Full text

, , +13

Optimal two-stage designs for phase II clinical trials

Richard Simon · Controlled Clinical Trials · 1989 · 3.6K citations

, , +10

Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials

BMJ · 1995 · 2.9K citations

, , +15